par Sculier, Jean-Paul 
;Meert, Anne-Pascale ;Berghmans, Thierry
Référence Lancet, 377, page (1810-1812)
Publication Publié, 2011
;Meert, Anne-Pascale ;Berghmans, Thierry Référence Lancet, 377, page (1810-1812)
Publication Publié, 2011
Article révisé par les pairs
| Titre: |
|
| Auteur: | Sculier, Jean-Paul; Meert, Anne-Pascale; Berghmans, Thierry |
| Informations sur la publication: | Lancet, 377, page (1810-1812) |
| Statut de publication: | Publié, 2011 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Angiogenesis Inhibitors -- administration & dosage |
| Antibodies, Monoclonal -- administration & dosage | |
| Antibodies, Monoclonal, Humanized | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Carcinoma, Non-Small-Cell Lung -- drug therapy -- mortality | |
| Disease-Free Survival | |
| Double-Blind Method | |
| Humans | |
| Lung Neoplasms -- drug therapy -- mortality | |
| Protein Kinase Inhibitors -- administration & dosage | |
| Quinazolines -- administration & dosage | |
| Receptor, Epidermal Growth Factor -- antagonists & inhibitors | |
| Salvage Therapy | |
| Survival Rate | |
| Vascular Endothelial Growth Factor A -- antagonists & inhibitors | |
| Note générale: | SCOPUS: no.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0140-6736 |
| info:doi/10.1016/S0140-6736(11)60740-X | |
| info:pii/S014067361160740X | |
| info:scp/79957835045 | |
| info:pmid/21621709 |
